Rhinaer Stylus
Device Ear Nose & Throat
PDI 08886479300184
General payments
$1,396,327
Research payments
$2,228,458
Through program year 2025, $1,396,327 in general payments and $2,228,458 in research payments were reported against Rhinaer Stylus (Ear Nose & Throat).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $286,237 | 5,431 |
| 2025 | Research | $377,404 | 66 |
| 2024 | General | $287,355 | 4,944 |
| 2024 | Research | $198,274 | 73 |
| 2023 | General | $244,178 | 3,592 |
| 2023 | Research | $242,826 | 77 |
| 2022 | General | $258,857 | 183 |
| 2022 | Research | $133,230 | 50 |
| 2021 | General | $319,700 | 870 |
| 2021 | Research | $1,276,724 | 141 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 80 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 51 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
15,020 general · 407 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.